# XXII earnings call intelligence

LOPJLB CallCard / temporal rollup · freemium · [stock page](https://www.lopjlb.com/stock/XXII) · [Earnings tab](https://www.lopjlb.com/stock/XXII?tab=earnings)

Updated: 2026-08-14T05:48:55

Quarters analyzed: 8

## Cross-quarter narrative

Across eight quarterly calls the company moved from an aggressive cash‑burn cut and balance‑sheet repair in early 2024 toward a VL‑low‑nicotine (VLN) branded‑product strategy by 2025‑26. Initial quarters emphasized debt‑for‑equity swaps, equity raises and a target of cash‑breakeven in Q1 2025, but that milestone slipped as the CMO volume ramp proved slower than expected and regulatory approvals lagged. By Q4 2024 the firm re‑positioned as a pure‑play tobacco player, launched a rebranded VLN line and began partner‑private‑label collaborations while continuing debt reduction, ultimately becoming debt‑free with $14 M cash in Q3 2025. The focus shifted to high‑margin VLN products, with Pinnacle and Smoker Friendly launches, and an expanded retail footprint aiming for 5,000 outlets by end‑2026. Regulatory uncertainty (state approvals, FDA low‑nicotine mandate, MRTP renewal) and execution risk around rate‑of‑sale remain persistent, while cash burn has narrowed but still limits runway. The profitability horizon has been pushed from Q1 2025 to H1 2026, reflecting the longer‑term nature of VLN adoption and the need for continued capital.

## Quarter one-liners

- **2026 Q1:** XXII Q1 2026: Revenue $4.1M (+16% seq), gross loss narrowing; VLN rollout expanding to target 5,000 outlets by year-end with new retail partnerships and marketing hire.
- **2025 Q3:** XXII Q3 2025: Debt-free with $14M cash, shifting from low-margin CMO to VLN branded products; 1,500 stores in 21 states, targeting 500k cartons breakeven, EBITDA breakeven goal Q2 2026.
- **2025 Q2:** 22nd Century shifts to high-margin VLN branded products with Pinnacle/Smoker Friendly launches, targets H1 2026 profitability amid FDA low-nicotine mandate tailwind.
- **2025 Q1:** 22nd Century reports Q1 2025 revenue up 50% sequentially to $6M, narrowing losses; targets H2 2025 breakeven via CMO contract repricing, VLN distribution expansion, and new product launches.
- **2024 Q4:** 22nd Century Group completes restructuring, repositions as pure-play tobacco company, relaunches VLN reduced-nicotine cigarettes with partner brands, targets EBITDA breakeven in Q4 2025 after debt reduction and CMO contract repricing.
- **2024 Q3:** 22nd Century reports Q3 revenue decline but highlights a stronger balance sheet, cost cuts, and a strategic push to expand its VLN low‑nicotine brand and CMO manufacturing business toward breakeven in Q1 2025.
- **2024 Q2:** 22nd Century cut net loss to $1.6M from $21M YoY, targets cash positive Q1 2025 via CMO volume ramp and VLN rebrand, but warns of bumpy road.
- **2024 Q1:** XXII Q1 2024: Cash burn cut to $2.5M from $15M; new CMO contracts and Pinnacle distribution ramping; targeting breakeven Q1 2025; debt reduced $8M via equity swaps; no analyst Q&A.

## Theme arcs

- **Cash‑burn reduction** (improving): Burn fell from $15M to $2.3M in Q1 2024 and continued to narrow, though still positive burn.
- **Balance‑sheet improvement** (improving): Debt swaps, equity raises and repayments left the firm debt‑free by Q3 2025.
- **VLN product rollout** (improving): Rebranding launched Q4 2024, followed by multiple branded SKUs and retail expansion through 2026.
- **CMO volume expansion** (deteriorating): Early optimism gave way to slower ramp and eventual wind‑down as focus shifted to VLN.
- **Regulatory risk** (stable): State approvals and FDA low‑nicotine rule remain pending, extending timelines.

## Guidance path

2024 Q1:vague → 2024 Q2:vague → 2024 Q3:maintained → 2024 Q4:maintained → 2025 Q1:maintained → 2025 Q2:maintained → 2025 Q3:maintained → 2026 Q1:vague

---

Research context only. Not personalized investment advice.

API: `GET /bff/api/bigfive/earnings-intel/XXII`